Drug-resistant TB

Other topics in this section

Drug-resistant TB: latest news

Drug-resistant TB resources

  • Multidrug-resistant tuberculosis

    Some strains of tuberculosis have become resistant to some of the standard drugs. These multidrug-resistant (MDR) strains have infected both people with HIV and HIV-negative...

    From:HIV treatments directory

  • Think TB

    TB is one of the major killers in people with HIV. This publication brings together research on the management of TB in people with HIV....

    From:Think TB

  • Drug-resistant TB

    TB that is resistant to isoniazid and rifampicin, and to other drugs as well, is becoming much more common. This is called multidrug-resistant TB (MDR-TB)...

    From:Booklets

Drug-resistant TB features

Drug-resistant TB news from aidsmap

More news

Drug-resistant TB news selected from other sources

  • The Union offers hope and practical advice on multidrug-resistant tuberculosis

    The Union is marking World TB Day this year by publishing a new guide that offers clear, practical advice on one of the trickiest aspects of "stopping TB" – how to manage the estimated 310,000 patients who have multidrug-resistant TB (MDR-TB).

    6 hours ago | International Union Against Tuberculosis and Lung Disease

  • Sluggish response risks squandering historic opportunity to tackle global drug-resistant tuberculosis

    If measures to tackle multidrug-resistant tuberculosis (MDR-TB) are not significantly stepped up, including addressing barriers that prevent both research into better drug combinations and treatment scale up, MDR-TB rates will continue to increase worldwide and a historic opportunity to improve abysmal cure rates will have been squandered, medical humanitarian organisation Médecins Sans Frontières (MSF) warned today.

    20 March 2013 | MSF

  • Tuberculosis: Europe’s Ticking Timebomb

    On World Tuberculosis Day the TB Europe Coalition called on the European Commission to substantially increase funding to fight tuberculosis in Europe. Tuberculosis causes not only illness and death, according to estimates, it costs EU Member States €15 million every week and €750 million every year.

    20 March 2013 | TB Europe Coalition

  • World Health Organization and Global Fund cite tuberculosis threat

    WHO and the Global Fund to Fight AIDS, TB and Malaria said today that strains of tuberculosis with resistance to multiple drugs could spread widely and highlight an annual need of at least US$ 1.6 billion in international funding for treatment and prevention of the disease.

    18 March 2013 | World Health Organization

  • Global Drug Facility achieves price reduction for drug-resistant TB treatments

    The Stop TB Partnership’s Global Drug Facility has reduced the price of several second-line drugs it supplies for the treatment of multidrug resistant tuberculosis (MDR-TB) by up to 26% compared to 2011 prices, resulting in a decrease in the overall cost of treatment.

    18 March 2013 | Stop TB Partnership

  • An Activist’s Guide to Bedaquiline (Sirturo)

    Bedaquiline (also known by its trade name, Sirturo, or as TMC207) is the first new drug from a new drug class to treat TB to be approved by the United States Food and Drug Administration (FDA) in over 40 years. This guide highlights important safety and efficacy data reported thus far and offers advocacy recommendations for activists to take forward. .

    12 March 2013 | Treatment Action Group

  • Ukraine: Curbing the MDR-TB Epidemic in Prisons

    Once considered a disease on the decline, tuberculosis (TB) has seen a resurgence in Ukraine and several other post-Soviet countries that endured social and economic tumult after the collapse of the Soviet Union.

    10 March 2013 | Doctors Without Borders

  • Dangerous TB Patient Nabbed On US Border

    In medical isolation in South Texas, 100 miles or so from Mexico's border, is a man who embodies one of U.S. health officials' greatest worries: He is the first person to cross and be held in detention while infected with one of the most severe types of drug-resistant tuberculosis known today.

    03 March 2013 | Wall Street Journal

  • Cochrane review gives thumbs up to GeneXpert test for detection of MDR-TB

    This systematic review published in The Cochrane Library provides timely advice to clinicians and policymakers in countries where TB is a major public health problem.

    01 February 2013 | Citizen News Service

  • French authorities fear drug-resistant tuberculosis from Eastern Europe

    For several months, French hospitals have been receiving increasing numbers of patients from Eastern Europe with a multi-drug-resistant tuberculosis (MDR TB).

    30 January 2013 | Euronews
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also